Related Experiment Video
Updated: Aug 12, 2025

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
Published on: August 1, 2018
Is Cirrhotic Cardiomyopathy Related to Cirrhosis Severity?
Subhash Chandra Dash1, Beeravelli Rajesh2, Suresh Kumar Behera3
1Department of General Medicine, Institute of Medical Sciences & SUM Hospital, Bhubaneswar, India.
Insights
Cirrhotic cardiomyopathy (CCM) is more common in severe liver cirrhosis. This study found that cardiac dysfunction, particularly systolic dysfunction, worsens with cirrhosis severity, impacting patient outcomes.
Area of Science:
- Cardiology
- Hepatology
- Internal Medicine
Background:
- Cirrhotic cardiomyopathy (CCM) is a significant complication of liver cirrhosis, contributing to increased patient morbidity and mortality.
- The relationship between CCM and the severity of liver cirrhosis remains incompletely understood, with contradictory findings in existing literature.
- Early diagnosis and understanding of CCM are crucial for managing patients with liver cirrhosis.
Purpose of the Study:
- To investigate the prevalence of cardiac dysfunction in an Indian population with liver cirrhosis.
- To explore the correlation between cirrhotic cardiomyopathy and the severity of liver cirrhosis, assessed using MELD and CTP scores.
- To identify specific patterns of cardiac dysfunction, including systolic and diastolic abnormalities, in patients with cirrhosis.
Main Methods:
- Ninety-six patients diagnosed with liver cirrhosis but without pre-existing cardiac conditions were enrolled.
- Participants underwent clinical evaluation, electrocardiography, and echocardiography to assess cardiac function.
- Cirrhosis severity was quantified using the Model for End-stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) scoring systems.
Main Results:
- Cirrhotic cardiomyopathy was diagnosed in 39.6% of patients.
- Patients with CCM exhibited significantly higher CTP (9.6±2.6 vs. 8.3±2.3) and MELD (19.72±4.9 vs. 17.41±4.1) scores compared to those without CCM.
- Systolic dysfunction and reduced left ventricular ejection fraction were more prevalent in advanced stages of cirrhosis (CTP-C).
Conclusions:
- Cirrhotic cardiomyopathy demonstrates a positive correlation with the severity of liver cirrhosis.
- Progressive decline in systolic cardiac function is observed as cirrhosis severity increases.
- Overt systolic dysfunction is particularly common in advanced stages of liver cirrhosis, underscoring the need for cardiac monitoring.
Objective:
Cirrhotic cardiomyopathy (CCM) is associated with increased morbidity and mortality in patients with liver cirrhosis. Yet, it remains an under-diagnosed entity. Further, its relation to the severity of cirrhosis is contradictory. We conducted this study on an Indian population to determine the cardiac dysfunctions in cirrhosis of the liver and correlations with etiologies and cirrhosis severity.
Methods:
This study enrolled patients with diagnosed liver cirrhosis without any cardiac disease or conditions affecting cardiac function. All participants were evaluated clinically, electrocardiographically, and echocardiographically. Cirrhosis severity was assessed by scores from the Model for End-stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) tests. Cirrhotic cardiomyopathy was defined as diastolic dysfunction and/or systolic dysfunction with QT prolongation.
Results:
Ninety-six patients were evaluated, and CTP-A stage of cirrhosis was found in 23 (24%), CTP-B in 42 (43.8%), and CTP-C in 31 (32.3%) cases. Systolic dysfunction was most frequent (P=0.014), and left ventricular ejection fraction was significantly reduced (P=0.001) in CTP-C stage of cirrhosis. Cirrhotic cardiomyopathy was found in 39.6% (n=38) of patients; CCM patients had significantly higher CTP scores (9.6±2.6 versus 8.3±2.3, P=0.012) as well as MELD scores (19.72±4.9 versus 17.41±4.1, P=0.015) in comparison to patients without CCM.
Conclusion:
Cirrhotic cardiomyopathy has a positive relationship with the severity of cirrhosis. Systolic function declines with the severity of cirrhosis, and overt systolic dysfunction can be present, particularly in the advanced stage of cirrhosis of the liver.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease I: Introduction

